PlainRecalls
CPSC Moderate Active

Acme United Corporation Recalls PhysiciansCare Brand Over-the-Counter Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

Reported: March 17, 2022 Initiated: March 17, 2022 #22733

Product Description

This recall involves the PhysiciansCare brand Extra Strength Non Aspirin, Aspirin, Extra Strength Pain Reliever, Ibuprofen, Medication Station, and Multi-Pack over-the-counter drugs. The products contain aspirin, acetaminophen, or ibuprofen. They are packaged in cardboard boxes of 50, 100, 250, and 500 tablets per box. Product Drug Tablet Amount Extra Strength Non Aspirin Acetaminophen (500 mg) 50 tablets 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Aspirin Aspirin (325 mg) 50 tablets 100 tablets 250 tablets 500 tablets Extra Strength Pain Reliever Acetaminophen (250 mg) Aspirin (250 mg) 100 tablets 250 tablets Ibuprofen Ibuprofen (200 mg) 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Medication Station / Multi-Pack Acetaminophen (500 mg) Aspirin (325 mg) Ibuprofen (200 mg) Antacid (420 mg) 4 boxes of 100 tablets each with outer station 4 boxes of 100 tablets each without outer station The Antacid is not subject to this recall.

Reason for Recall

The recalled over-the-counter products contain regulated substances (aspirin, acetaminophen, or ibuprofen) which must be in child resistant packaging when being used in the household as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Remedy

Consumers should immediately store the recalled products in a safe location out of reach of children and contact Acme United for information on how to dispose of or return the product and receive a full refund. Acme United is contacting all purchasers directly.

Details

Units Affected
About 165,000
Official Source
https://www.cpsc.gov/Recalls/2022/Acme-United-Corporation-Recalls-PhysiciansCare-Brand-Over-the-Counter-Drugs-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning-Recall-Alert

Frequently Asked Questions

What product was recalled? ▼
This recall involves the PhysiciansCare brand Extra Strength Non Aspirin, Aspirin, Extra Strength Pain Reliever, Ibuprofen, Medication Station, and Multi-Pack over-the-counter drugs. The products contain aspirin, acetaminophen, or ibuprofen. They are packaged in cardboard boxes of 50, 100, 250, and 500 tablets per box. Product Drug Tablet Amount Extra Strength Non Aspirin Acetaminophen (500 mg) 50 tablets 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Aspirin Aspirin (325 mg) 50 tablets 100 tablets 250 tablets 500 tablets Extra Strength Pain Reliever Acetaminophen (250 mg) Aspirin (250 mg) 100 tablets 250 tablets Ibuprofen Ibuprofen (200 mg) 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Medication Station / Multi-Pack Acetaminophen (500 mg) Aspirin (325 mg) Ibuprofen (200 mg) Antacid (420 mg) 4 boxes of 100 tablets each with outer station 4 boxes of 100 tablets each without outer station The Antacid is not subject to this recall.. Recalled by Acme United of Rocky Mount, North Carolina. Units affected: About 165,000.
Why was this product recalled? ▼
The recalled over-the-counter products contain regulated substances (aspirin, acetaminophen, or ibuprofen) which must be in child resistant packaging when being used in the household as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
What should consumers do? ▼
Consumers should immediately store the recalled products in a safe location out of reach of children and contact Acme United for information on how to dispose of or return the product and receive a full refund. Acme United is contacting all purchasers directly.
Which agency issued this recall? ▼
This recall was issued by the CPSC on March 17, 2022. Severity: Moderate. Recall number: 22733.

Related Recalls

FDA Drug Moderate

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…

Unichem Pharmaceuticals USA Inc. · 2026-02-11
FDA Drug Critical

Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…

Green Lumber Holdings, LLC · 2026-02-11
FDA Drug Moderate

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…

Granules Pharmaceuticals Inc. · 2026-02-11
FDA Drug Critical

Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…

SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11
FDA Drug Critical

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

HANDELNINE GLOBAL LLC · 2026-02-11

Explore Related Data

Vehicle Safety → Drug Information →